Clin2
NCT07432386Possibly a fitNot yet recruiting

Methotrexate vs Apremilast for Itching in Psoriasis

PsoriasisPruritus

Treatments studied

Part of Skin clinical trials.

This study compares two oral medications—methotrexate and apremilast—to see which works better for relieving itching in people with psoriasis. If you have psoriasis and bothersome itching, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
80 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have been diagnosed with psoriasis.
  • You have itching (pruritus) related to your psoriasis.
  • You are willing to take either methotrexate or apremilast tablets.
  • You have not had any systemic psoriasis treatment in the last 4 weeks.
  • You are not pregnant or breastfeeding, and have no serious liver, kidney, or blood problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07190391Not yet recruiting
Apremilast for moderate-to-severe psoriasis

This study tests a medicine called apremilast (brand name ApoLla) to see how well it works and how safe it is for people with moderate to severe psoriasis. If you have had psoriasis for 6 months or more and have not taken apremilast before, you may be a fit.

NCT07261306Recruiting· Early Phase 1
Methotrexate vs tofacitinib pills for plaque psoriasis

This study compares two oral pill treatments—methotrexate and tofacitinib—for people with chronic plaque psoriasis that is moderate to severe and hasn't responded well to creams. The goal is to see which pill works better at clearing skin.

Lahore, Punjab Province
NCT07366268Not yet recruiting
Apremilast cream for plaque psoriasis

This study tests a new cream form of the drug apremilast for mild plaque psoriasis that covers no more than 10% of your body. It aims to see if the cream is safe and works well for treating small patches of psoriasis.

NCT07086924Recruiting
Gene change and methotrexate response in psoriasis

This study looks at a specific gene change (called TRAF3IP2) in people with psoriasis or psoriatic arthritis who are about to start methotrexate. The goal is to see if the gene affects how well the treatment works or if it causes side effects.

Qina
NCT07432815Recruiting· Phase 4
Psoriasis with depression: methotrexate plus an antidepressant

This trial tests if adding an antidepressant (escitalopram) to standard methotrexate treatment works better than methotrexate alone for people who have both psoriasis and depression or anxiety. If you have moderate to severe psoriasis and also struggle with depression or anxiety, this study might offer a way to treat both conditions together.

Cairo, Cairo Governorate
NCT05500794Recruiting
Meditation for itch from psoriasis or eczema

This trial studies whether meditation can reduce itching and improve quality of life in adults with plaque psoriasis or atopic dermatitis (eczema). It may help by calming the mind and reducing discomfort related to inflammatory skin disease.

Paris

Hear when a new Psoriasis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.